Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Arcutis, Inc.”

6 pharma patents match "Arcutis, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "Arcutis, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “Arcutis, Inc.” · 30,257 patents in full index Clear search

  1. US 10940142

    Inhibition of crystal growth of roflumilast

    Arcutis, Inc. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted

  2. US 10172841

    Inhibition of crystal growth of roflumilast

    Arcutis, Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  3. US 10105354

    Inhibition of crystal growth of roflumilast

    Arcutis, Inc. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  4. US 9907788

    Inhibition of crystal growth of roflumilast

    Arcutis, Inc. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted

  5. US 9895359

    Inhibition of crystal growth of roflumilast

    Arcutis, Inc. · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  6. US 9884050

    Inhibition of crystal growth of roflumilast

    Arcutis, Inc. · Granted Feb 6, 2018 · Expires Feb 1, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.